Welcome to our dedicated page for AMERICAN HEALTHCARE REIT SEC filings (Ticker: AHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
American Healthcare REIT's SEC filings reveal the operational details behind this healthcare property portfolio. The company's 10-K annual reports break down rental income by property type—skilled nursing facilities, senior housing, and medical office buildings—showing which segments drive performance. Our AI highlights these segment breakdowns without requiring you to search through hundreds of pages.
For income investors, the quarterly 10-Q filings track the metrics that matter: occupancy rates across the portfolio, lease expiration schedules, and the financial health of major tenants. Healthcare REITs depend on their operators' ability to pay rent, and these filings disclose tenant concentration and any rental collection issues.
Form 4 insider transactions show when executives and directors buy or sell AHR shares. Insider activity in REITs can signal management's confidence in dividend sustainability and portfolio valuation. Track these transactions alongside earnings announcements for a complete picture of insider sentiment.
The company's 8-K filings announce material events including property acquisitions, dispositions, public offerings, and dividend declarations. Healthcare REITs frequently file 8-Ks when expanding their portfolios, making these filings useful for tracking growth activity in real time.
Proxy statements (DEF 14A) detail executive compensation structures, board composition, and governance matters. For a REIT, these filings reveal how management incentives align with shareholder interests in dividend growth and portfolio performance.
American Healthcare REIT, Inc. director Jeffrey T. Hanson filed a Form 4 reporting sales of company common stock and his indirect holdings. On 12/22/2025, a trust associated with him sold 35,570 shares of common stock at a weighted average price of $48.3753 per share. On 12/23/2025, the same trust sold an additional 19,208 shares at a weighted average price of $48.4012 per share, after which the trust no longer held shares.
Hanson also reports indirect holdings through several retirement and pension accounts, including IRAs, 401(k) plans, and a defined benefit pension plan. In addition, he reports 1,268,643 OP Units in American Healthcare REIT Holdings, LP held by AHI Group Holdings, LLC, which he owns and controls with two other executives. He states that he is reporting these OP Units for transparency and continues to disclaim beneficial ownership beyond his pecuniary interest.
American Healthcare REIT Inc. insider Jeffrey T Hanson has filed to sell 54778 common shares under Rule 144. The planned sale, through Merrill on the NYSE, has an aggregate market value of 2649904, while 176908238 shares of the issuer are outstanding. The shares were mainly acquired between 2014 and 2018 through an Executive Stock Purchase Plan, plus 5762 shares received via gift on 08/09/2023. Over the past 3 months, Hanson has already sold 20010 common shares for gross proceeds of 994105 on 11/10/2025.
American Healthcare REIT, Inc. reported that its board of directors authorized a fourth quarter 2025 cash distribution of $0.25 per share of common stock. This quarterly amount corresponds to an annualized distribution rate of $1.00 per share for the period from October 1, 2025 through December 31, 2025.
The distribution will be paid in cash on or about January 16, 2026 to stockholders of record as of the close of business on December 31, 2025. The company also made available a press release with additional details as an exhibit to this report.
American Healthcare REIT, Inc. entered into an additional forward sale agreement covering 1,215,000 shares of its common stock in connection with the full exercise of the underwriter’s option from a previously closed public offering of 8,100,000 shares. A forward seller borrowed and sold these 1,215,000 shares to hedge the forward purchaser’s obligations.
The company currently plans to deliver 1,215,000 shares to the forward purchaser on one or more dates no later than May 20, 2027, in exchange for cash based on the public offering price, less underwriting discounts and commissions and subject to adjustments. The company intends to contribute the net proceeds to its operating partnership, which plans to use the funds for general corporate purposes, including potential future investments.
American Healthcare REIT, Inc. closed a public offering of 8,100,000 shares of its common stock through a forward sale structure. Under an underwriting agreement with RBC Capital Markets and an affiliate acting as forward purchaser, the shares were borrowed and sold on November 24, 2025 to hedge the forward sale agreement.
The company expects, subject to its right to elect cash or net share settlement, to deliver 8,100,000 shares to the forward purchaser on one or more dates no later than May 20, 2027 in exchange for cash proceeds per share based on the public offering price, less underwriting discounts and commissions and subject to adjustments. The underwriters also have a 30-day option to purchase up to 1,215,000 additional shares.
The company intends to contribute the net proceeds from settling the forward sale agreement to its operating partnership in exchange for limited partnership units, and the operating partnership plans to use these funds for general corporate purposes, including potential future investments.
American Healthcare REIT, Inc. is offering 8,100,000 shares of common stock through a forward sale agreement with Royal Bank of Canada, with up to 9,315,000 shares if the underwriter’s option is fully exercised. The forward purchaser or its affiliate will initially borrow and sell the shares to the underwriter at an initial forward sale price of $47.75 per share, and the company will receive no proceeds from that sale.
Assuming full physical settlement of the forward sale agreement within approximately 18 months, the company estimates net cash proceeds of about $386.4 million, or $444.4 million if the option is fully exercised, based on the $47.75 initial forward price. After settlement, total common stock outstanding is expected to be 186,264,566 shares, compared with 178,164,566 shares outstanding as of November 14, 2025.
The company plans to contribute the net proceeds to its operating partnership for general corporate purposes, including potential healthcare real estate investments. As a REIT, it maintains a 9.9% ownership limit on its capital stock to help preserve REIT status, and warns that the forward structure can create dilution and, in certain cash or net share settlement scenarios, potential cash or share obligations to the forward purchaser.
American Healthcare REIT, Inc. is offering 8,100,000 shares of common stock, with an additional 1,215,000-share option, through a forward sale agreement with Royal Bank of Canada. The forward purchaser will borrow and sell the shares now, while the company expects to physically settle the agreement and receive cash proceeds within about 18 months, although it can instead choose cash or net share settlement, which could result in no proceeds and potential cash or share payments to the bank.
Shares outstanding were 178,164,566 as of November 14, 2025, and are expected to be 186,264,566 after full physical settlement. AHR continues to expand, having closed over $575 million of acquisitions in 2025 and holding a $288.5 million pipeline, supported by a $1.0 billion at-the-market program and prior forward sales for 2,153,436 shares.
American Healthcare REIT (AHR) executive Mark E. Foster (EVP, GC & Secretary) reported an open-market sale of 1,500 shares of common stock on 11/11/2025 at a $49.3531 weighted average price (Transaction Code: S).
The sale was executed in multiple trades between $49.35 and $49.37. Following the transaction, Foster beneficially owns 57,600 shares directly.
American Healthcare REIT (AHR) received a Form 144 notice indicating a planned sale of 1500 common shares. The filing lists an aggregate market value of 74030, with an approximate sale date of 11/11/2025 on the NYSE, using broker Merrill (8890 Lyra Drive, Columbus, OH).
The shares to be sold were acquired via Restricted Stock Vesting on 03/25/2025 in the amount of 1500. Over the prior three months, a related sale shows 3850 common shares with gross proceeds of 161156 by Mark Foster. The table also lists 176908238 shares outstanding.
Form 144 is a notice of intent to sell restricted or control securities and is an administrative disclosure rather than a financing transaction.
American Healthcare REIT, Inc. (AHR) received an amended Schedule 13G/A (Amendment No. 3) from Wellington affiliates reporting passive beneficial ownership. The filing lists 8,658,610 shares beneficially owned, representing 5.14% of the common stock as of the event date 09/30/2025.
Wellington reports 0 shares with sole voting or dispositive power, 6,564,421 with shared voting power, and 8,658,610 with shared dispositive power. The securities are held of record by clients of Wellington investment advisers, and no single client is known to hold more than five percent of the class.
FAQ
What is the current stock price of AMERICAN HEALTHCARE REIT (AHR)?
What is the market cap of AMERICAN HEALTHCARE REIT (AHR)?
